NCT02697864 A Study Comparing Amounts of Tafamidis In The Blood Without Food Status COMPLETED Phase PHASE1
NCT02697773 Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee Status COMPLETED Phase PHASE3
NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Status RECRUITING Phase PHASE2
NCT02689167 Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT02687542 Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Status TERMINATED Phase PHASE2
NCT02687191 Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage Status TERMINATED Phase PHASE1
NCT02684006 A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) Status COMPLETED Phase PHASE3
NCT02680847 Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain Status TERMINATED Phase PHASE4
NCT02679755 Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE4
NCT02679170 Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS) Status COMPLETED Phase N/A
NCT02676154 Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI) Status COMPLETED Phase PHASE2
NCT02674386 Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement Status COMPLETED Phase PHASE3
NCT02669771 Long-Term Specified Drug Use-Results Survey for Xtandi Capsule Status COMPLETED Phase N/A
NCT02668666 Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT02667223 Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase Status TERMINATED Phase PHASE1
NCT02664935 National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2